[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"delivery-room-resuscitation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:delivery-room-resuscitation":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,55],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":36,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":43,"lastUpdatePostDateStruct":44,"startDateStruct":47,"completionDateStruct":49,"leadSponsor":51,"locationsCount":54},"100625192","supraglottic-airway-for-resuscitation-in-preemies-100625192",false,"NCT07419438","Supraglottic Airway for Resuscitation in Preemies","Supraglottic Airway Interface for Positive Pressure Ventilation During Delivery Room Resuscitation of Premature Infants: A Pilot Feasibility Trial","SUPREEMIE","Inclusion Criteria:\n\n* Gestational age 29 0\u002F7 to 33 6\u002F7 weeks at birth\n* Estimated fetal weight \\>\u002F= 1000 grams at birth\n* Clinical decision to initiate PPV\n* Parental informed consent\n\nExclusion Criteria:\n\n* Major anomalies or aneuploidy\n* Palliative care planned or considered\n* Not resuscitated in the infant resuscitation room","ALL","0 Days","1 Day",{"count":21,"type":22},20,"ESTIMATED","INTERVENTIONAL",[25],"NA","The goal of this single-arm intervention trial is to learn whether using a supraglottic airway (SA) as the primary interface for positive pressure ventilation (PPV) is feasible during delivery room resuscitation of premature infants. This study will be conducted in premature infants born between 29 0\u002F7 and 33 6\u002F7 weeks' gestation who require PPV at birth.\n\nThe main question it aims to answer is: Is it feasible to use a supraglottic airway as the primary interface to provide effective PPV during delivery room resuscitation in 29 0\u002F7 to 33 6\u002F7 weeks' gestation premature infants?\n\nParticipants will (1)Be screened prenatally and have informed consent obtained from the birth parent prior to delivery; (2)Be rescreened for eligibility on the day of delivery before receiving the study intervention; (3)Receive PPV using a supraglottic airway as the primary ventilation interface if resuscitation is required at birth; and (4)Have clinical and procedural data collected during delivery room resuscitation and for up to 24 hours after birth.",[28,29,30,31,32,33,34,35],"Respiratory Failure","Premature Neonates","Delivery Room Resuscitation","Positive Pressure Ventilation","Neonatal Resuscitation","Supraglottic Airway","Laryngeal Mask","Laryngeal Mask Airways",[37,38,30,39,40,33,41,35],"Respiratory failure","Premature neonates","Positive pressure ventilation","Neonatal resuscitation","laryngeal mask","RECRUITING","2026-04-16",{"date":45,"type":46},"2026-04-17","ACTUAL",{"date":48,"type":46},"2026-03-13",{"date":50,"type":22},"2026-10",{"name":52,"class":53},"University of Pennsylvania","OTHER",1,{"id":56,"slug":57,"hasResults":11,"nctId":58,"briefTitle":59,"officialTitle":60,"acronym":61,"eligibilityCriteria":62,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":63,"targetDuration":4,"studyType":23,"phases":65,"briefSummary":66,"conditions":67,"keywords":70,"overallStatus":42,"whyStopped":4,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":80},"100604546","supraglottic-airway-for-resuscitation-trial-100604546","NCT07150923","Supraglottic Airway for Resuscitation Trial","Comparing Two Multicomponent Strategies To Promote Supraglottic Airway Implementation During Neonatal Resuscitation","SUGAR","Population 1: Hospital Staff\n\nPopulation 1a: Clinical providers and administrators who complete study questionnaires\n\nClinical provider 1a inclusion criteria:\n\n* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation\n* Fluent in English\n\nAdministrator 1a inclusion criteria\n\n* Oversee the care of newborns on a local level (e.g. nurse manager) or a hospital level (e.g. Chief Quality and Safety Officer)\n* Fluent in English\n\nClinical provider and administrator exclusion 1a criteria: No exclusion criteria\n\nPopulation 1b: Clinical providers who participate in qualitative interviews\n\nClinical provider 1b inclusion criteria:\n\n* Employed full-time by the hospital, affiliated practice, or affiliated university in a role that involves newborn resuscitation\n* Fluent in English\n\nClinical provider 1b exclusion criteria: No exclusion criteria\n\nPopulation 2: Patients who receive neonatal resuscitation at birth\n\nInclusion Criteria:\n\n* Inborn (not transferred to the hospital after birth)\n* ≥34 weeks' gestation at birth, based on best obstetrical estimate\n* Received PPV during neonatal resuscitation (as per provider's clinical assessment)\n\nExclusion Criteria:\n\n* Congenital diaphragmatic hernia\n* Airway anomalies",{"count":64,"type":22},36503,[25],"This is a hybrid type 3 effectiveness-implementation parallel cluster randomized superiority trial designed to compare two strategies to promote early supraglottic airway (SA) rescue during neonatal resuscitation, with a focus on implementation outcomes.",[32,30,31,68,33,35,69],"Infant, Newborn","Implementation Research",[32,30,39,33,35,69,68],"2026-02-26",{"date":73,"type":46},"2026-02-27",{"date":75,"type":46},"2026-01-01",{"date":77,"type":22},"2029-09",{"name":79,"class":53},"Children's Hospital of Philadelphia",30]